KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Illumina (ILMN) Cash & Equivalents (2016 - 2025)

Illumina's Cash & Equivalents history spans 17 years, with the latest figure at $1.4 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 25.82% year-over-year to $1.4 billion; the TTM value through Dec 2025 reached $1.4 billion, up 25.82%, while the annual FY2025 figure was $1.4 billion, 25.82% up from the prior year.
  • Cash & Equivalents reached $1.4 billion in Q4 2025 per ILMN's latest filing, up from $1.0 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $4.4 billion in Q2 2021 to a low of $869.0 million in Q3 2024.
  • Average Cash & Equivalents over 5 years is $1.5 billion, with a median of $1.1 billion recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: soared 137.06% in 2021, then crashed 69.52% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $1.1 billion in 2021, then dropped by 7.41% to $1.0 billion in 2022, then increased by 4.8% to $1.0 billion in 2023, then rose by 7.54% to $1.1 billion in 2024, then grew by 25.82% to $1.4 billion in 2025.
  • Per Business Quant, the three most recent readings for ILMN's Cash & Equivalents are $1.4 billion (Q4 2025), $1.0 billion (Q3 2025), and $934.0 million (Q2 2025).